The Food and Drug Administration silenced one of its drug experts who raised safety concerns weeks before Merck amp Co. yanked the blockbuster drug Vioxx due to increased risks for heart attack and strokes.
The issue of drug advertising directly aimed at consumers was thrust into the news recently when Merck withdrew its arthritis painkiller Vioxx from the market, citing studies indicating a risk of heart attacks or strokes.
Pfizer Inc. warned doctors on Friday that one of its bestselling painkillers, Bextra, might increase the risk of a heart attack or stroke in coronary artery bypass surgery patients.
